Induction of p16INK4A mediated by β-catenin in a TCF4-independent manner: Implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells

International Journal of Cancer

Volumn 119, Issue 10, 2006, Pages 2294-2303

  Saegusa, Makoto ^a   Hashimura, Miki ^a   Kuwata, Takeshi ^b   Hamano, Mieko ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

catenin; Cyclin D1; Endometrial carcinoma; p16INK4A; p21WAF1; pRb

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P14ARF; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN; T CELL FACTOR 4 PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TCF4 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; TUMOR GROWTH; CELL CULTURE; DISEASE COURSE; DOWN REGULATION; ENDOMETRIUM TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; METABOLISM; MORULA; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MORULA; PLASMIDS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33749622427     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22112     Document Type: Article

References (26)

1. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastoma-protein- dependent cell-cycle inhibition by the tumor suppressor p16. Nature 1995;375:503-6.
2. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Med 1997;3:313-19.
3. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997;275:1787-90.
4. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6.
5. Gat U, DasGupta R, Degenstein L, Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 1998;95:605-14.
6. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J 1999;18:5931-42.
7. Damals A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J 2001;17:4912-22.
8. Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A. PML is a target gene of β-catenin and plakoglobin, and coactivates β-catenin-mediated transcription. Cancer Res 2002;62:5947-54.
9. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, Advani H. The significance of squamous differentiation in endometrial carcinoma. Cancer 1991;68:2293-302.
10. Saegusa M, Okayasu I. Frequent nuclear β-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 2001;194:59-67.
11. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. β-Catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 2004;164:1739-49.
12. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Upregulation of TCF4 expression as a transcriptional target of β-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells. Lab Invest 2005;85:768-79.
13. KIP1, and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer 2001;92:1177-89.
14. Saegusa M, Okayasu I. Down-regulation of bcl-2 expression is closely related to squamous differentiation and progesterone therapy in endometrial carcinomas. J Pathol 1997;182:429-36.
15. Jho E-H, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002; 22:1172-83.
16. Kuramoto H, Hamano M, Imai M, Fujisawa T, Kamata Y, Arai T, Kawaguchi M. Hec-1 cells: establishment of an in vitro experimental system in endometrial carcinoma. In: Kuramoto H, Nishida M, eds. Cell and molecular biology of endometrial carcinoma. Tokyo: Springer-Verlag, 2003. 3-34.
17. Nishida M. Ishikawa cells: opening of in vitro hormone research on endometrial carcinoma. In: Kuramoto H, Nishida M, eds. Cell and molecular biology of endometrial carcinoma. Tokyo: Springer-Verlag, 2003. 35-60.
18. Saegusa M, Hashimura M, Yoshida T, Okayasu I. β-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 2001;84:209-17.
19. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
20. INK4A and is a region of low proliferation. Am J Pathol 2001;159:1613-17.
21. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a wnt-1- and β-catenin-responsive oncogene. Gene Dev 2000;16:585-95.
22. Filali M, Cheng N, Abbott D, Leontiev V, Engelhardt JF. Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J Biol Chem 2002;36:33398-410.
23. Waf1 in HeLa cells. FEBS Lett 2004;564:199-204.
24. Gill RM, Hamel PA, Zhe J, Zacksenhaus E, Gallie BL, Phillips RA. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ 1994;5: 467-74.
25. An B, Dou QP. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1β-converting enzyme-like protease as candidate. Cancer Res 1996;56:438-42.
26. Stein GH, Drullinger LF, Soulard A, Dulic V. Differential roles for cyclin-dependent kinase inhibitor p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999;19:2109-17.